MENU
+Compare
ALNY
Stock ticker: NASDAQ
AS OF
Jul 7 closing price
Price
$324.13
Change
-$7.78 (-2.34%)
Capitalization
42.26B

ALNY Alnylam Pharmaceuticals Forecast, Technical & Fundamental Analysis

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more

Industry: #Biotechnology
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALNY with price predictions
Jul 07, 2025

Aroon Indicator for ALNY shows an upward move is likely

ALNY's Aroon Indicator triggered a bullish signal on July 07, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 188 similar instances where the Aroon Indicator showed a similar pattern. In of the 188 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALNY advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ALNY moved out of overbought territory on July 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for ALNY turned negative on July 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALNY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALNY broke above its upper Bollinger Band on June 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALNY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALNY's P/B Ratio (370.370) is very high in comparison to the industry average of (16.718). P/E Ratio (0.000) is within average values for comparable stocks, (58.312). ALNY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.371). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (17.730) is also within normal values, averaging (263.500).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALNY is expected to report earnings to rise 6,449.00% to -65 cents per share on July 31

Alnylam Pharmaceuticals ALNY Stock Earnings Reports
Q2'25
Est.
$-0.65
Q1'25
Beat
by $0.92
Q4'24
Beat
by $0.64
Q3'24
Beat
by $0.43
Q2'24
Beat
by $1.61
The last earnings report on May 01 showed earnings per share of 0 cents, beating the estimate of -93 cents. With 1.29M shares outstanding, the current market capitalization sits at 42.26B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UGL35.240.07
+0.20%
ProShares Ultra Gold
VSDM75.620.02
+0.03%
Vanguard Short Duration Tax-Exm Bd ETF
VFL9.72-0.02
-0.15%
abrdn National Municipal Income Fund
MART35.96-0.17
-0.47%
AllianzIM U.S. Large Cp Buffer10 Mar ETF
RSPT41.22-0.43
-1.03%
Invesco S&P 500® Equal Weight Tech ETF

ALNY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-2.34%
IONS - ALNY
53%
Loosely correlated
-2.84%
SGMO - ALNY
42%
Loosely correlated
-2.87%
RARE - ALNY
37%
Loosely correlated
-0.75%
ALLO - ALNY
37%
Loosely correlated
-2.52%
INSM - ALNY
36%
Loosely correlated
-1.31%
More